Text Size

Automated Assessment of Mental Health in the Workplace

This study has been completed.
Sponsor:
Collaborator:
Centers for Disease Control and Prevention
Information provided by:
Boston Medical Center
ClinicalTrials.gov Identifier:
NCT00134576
First received: August 23, 2005
Last updated: June 1, 2010
Last verified: May 2010
History of Changes
  Purpose

The purpose of this study is to design, refine, and test for the effectiveness of a computer-based telephone system (Telephone-Linked Communications for Detection of Mental Health Disorders in the Workplace; TLC-Detect) that will screen workers for mental health distress; educate them about seeking treatment; and follow up with them over a 6 month period.


Condition Intervention
Mental Disorders
 Behavioral: Computer Assisted Education for Behavioral Change

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Factorial Assignment
Masking: Open Label
Official Title: Automated Assessment of Mental Health in the Workplace

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Boston Medical Center:

Primary Outcome Measures:
  • Absenteeism and presentism (functionality at work), measured every three months for 6 months [ Time Frame: 6 months ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Treatment status, timing of measurement depends upon symptom severity [ Time Frame: 6 months ] [ Designated as safety issue: No ]
  • Health status measured every three months for 6 months [ Time Frame: 6 months ] [ Designated as safety issue: No ]

Estimated Enrollment: 150
Study Start Date: May 2007
Study Completion Date: January 2009
Primary Completion Date: September 2008 (Final data collection date for primary outcome measure)
Intervention Details:
    Behavioral: Computer Assisted Education for Behavioral Change
    TLC-Detect will provide subjects in the intervention group with information about each diagnosed mental health disorder. TLC-Detect will then give the Treatment Module and will tell the intervention subjects that it will call back in one month for a follow-up or the next week if a subject is comorbid with other disorders.
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Employment with benefits at Boston Medical Center, Boston University, or Florida Power and Light Company
  • Ability to speak and understand conversational English
  • > 18 years of age
  • Access to a touch-tone telephone
  • Screen positive for the World Health Organization (WHO)-5 Well-Being Index

Exclusion Criteria:

  • Being under treatment (medication or therapy) for a mental health disorder
  • Taking medication for a serious/major medical disorder that interferes with normal life
  • Taking medication prescribed for mental health treatment on a daily basis
  • Diagnosed with schizophrenia
  • Planning to go on leave for over 6 months
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00134576

Locations
United States, Massachusetts
Boston Medical Center
Boston, Massachusetts, United States, 02118
Sponsors and Collaborators
Boston Medical Center
Centers for Disease Control and Prevention
Investigators
Principal Investigator: Ramesh Farzanfar, PhD Boston University
  More Information

No publications provided

Responsible Party: Dr. Ramesh Farzanfar, Boston University
ClinicalTrials.gov Identifier: NCT00134576     History of Changes
Other Study ID Numbers: RO1 DP000116
Study First Received: August 23, 2005
Last Updated: June 1, 2010
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Mental Disorders
Psychotic Disorders
Schizophrenia and Disorders with Psychotic Features

ClinicalTrials.gov processed this record on June 18, 2013